PATENT CLAIM ANALYSIS

Application Number: 15869672
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "021900"]

Abstract:
Embodiments of this invention provide compositions and methods for therapeutic use of diketopiperazines including cyclic G-2-Allyl Proline and other cyclic Glycyl Proline compounds to treat symptoms of Autism Spectrum Disorders and Neurodevelopmental Disorders as well as manufacture of medicaments including tablets, capsules, liquid formulations, gels, injectable solutions, and other formulations that are useful for treatment of such conditions.

Claim (Index 14):
The method of  claim 8  where R 1 =methyl, R 2 \u2550R 3 \u2550H, R 4  and R 5  taken together are \u2014CH 2 \u2014(CH 2 ) 2 \u2014CH 2 \u2014, X 1 \u2550NH, X 2 \u2550CH 2 .

Metadata:
- Claim Count in Document: 62.0
- Percentile: 86.0
- Lexical Diversity: 1.42222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15004218', '13699087', '14605420', '13043215', '14314802']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8024313036227915
- 35 USC 102 Novelty (BERT): 0.7197624893832779
- Combined Prediction Score: 0.7941644221988401
- Mean Citation Score: 470.835938
- Max Citation Score: 816.6358
- Similarity Product: 760.4450489528657

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test